

CLIA stands for Chemiluminescent Immunoassay. It is a lab test used to detect substances in blood. These can be antigens, antibodies, hormones, or drugs.
The test works on the principle of antigen-antibody binding. CLIA is popular because it is very sensitive, gives results fast, and can measure a wide range of levels.
Today, ready-to-use Chemiluminescent Immunoassay (CLIA) kits are available. They are used in diagnostics, research, and biotech labs. These kits save time and make the test easy to use. CLIA has many formats. Let’s look at the most common ones.
In this format, antibodies or antigens are immobilized directly on a solid surface, such as microtiter plates, tubes, or wells. After the immune reaction, unbound reagents are washed away, and the chemiluminescent signal is measured.
In this method, antibodies or antigens are coated onto magnetic beads. After the immune reaction, magnetic separation is used to isolate the bound from the unbound reagents. This method boosts assay speed and sensitivity.
In the direct format, the antigen is immobilized on a solid surface. In this, a chemiluminescent-labeled antibody binds directly to it. The intensity of the emitted light corresponds to the amount of antigen present.
Direct CLIA is often used for applications where analyte concentrations are relatively high and testing speed is prioritized.
Indirect CLIA involves two antibodies: a primary antibody that binds to the antigen and a secondary antibody conjugated with a chemiluminescent label that binds to the primary antibody. This method helps in signal amplification and thereby increases assay sensitivity.
Indirect CLIA is widely used in clinical testing, especially for the detection of antibodies in infectious disease screening.
The sandwich format is one of the most popular CLIA designs, especially for the detection of larger molecules like proteins, hormones, and antigens. It is called a “sandwich” because the target analyte is captured between two antibodies.
Sandwich CLIA is commonly used for hormone assays (e.g., thyroid-stimulating hormone, insulin), cancer biomarkers, and infectious disease antigen testing.
In competitive CLIA, the sample analyte competes with a chemiluminescent-labeled analyte (tracer) for a limited number of binding sites on a specific antibody. The signal generated is inversely proportional to the analyte concentration in the sample. Higher analyte levels result in lower luminescence.
Unlike other formats, homogeneous CLIA does not require separation of bound and unbound reagents. Instead, the chemiluminescent signal changes depending on whether the immune complex is formed. This makes the assay simpler and faster.
Homogeneous CLIA is often applied in large-scale clinical screenings where speed and automation are essential.
CLIA is widely used in medical diagnostics, pharmaceutical research, food safety, and environmental monitoring. However, the choice of CLIA format depends on the analyte types, required sensitivity, sample complexity, and laboratory workflow. So, make sure you know your needs before using CLIA for your experiments.